维普期刊资源整合服务平台（V6.5）

101篇 您的检索式：期刊名="Cardiometab Syndr"

选中清除导出查看参考文献查看引证文献引用追踪共6页首页上一页第1页下一页末页 /6 跳转

	题名	作者	年代	出处	被引量
1	Myocardial myocyte remodeling and fibrosis in the cardiometabolic syndrome显示文摘	Hayden MR Chowdhury N Govindarajan G	2006	J Cardiometab Syndr2006，1，5：	1
2	Resveratrol:biologic and therapeutic implications显示文摘	SADRUDDIN S ARORA R	2009	J Cardiometab Syndr2009，4，2：	1
3	Involvement of the pancreatic renin-angiotensin system in insulin resistance and the metabolic syndrome 显示文摘	Leung P S de Gasparo M	2006	J Cardiometab Syndr2006，1，：	1
4	Statin pleiotropyagainst renal injury显示文摘	Kostapanos MS Liberopoulos EN Elisaf MS	2009	J Cardiometab Syndr2009，4，1：	1
5	The role of adiponectin in obesity, diabetes, and cardiovascular disease 显示文摘	KAWANO J ARORA R	2009	J Cardiometab Syndr2009，4，1：	1
6	Involvement of the pancreaticrenin-angiotensin system in insulin resistance and the met-abolic syndrome显示文摘	Leung PS de Gasparo M	2006	J Cardiometab Syndr2006，1，3：	1
7	Demographic analyses of the effects of carvedilol vs metoprolol on glycemic control and insulin sensitivity in patients with type 2 diabetes and hypertension in the Gly- cemic Effects in Diabetes Mellitus: Carvedilol-Metoprolol Comparison in Hypertensives (GEMINI) study 显示文摘	Phillips RA Fonseca V Katholi RE	2008	J Cardiometab Syndr2008，3，：	1
8	High cardi- ovascular risk in patients with diabetes and the car- diometabolic syndrome: mandate for statin therapy 显示文摘	Oonzalez GL Manrique CM Sowers JR	2006	J Cardiometab Syndr2006，1，3：	1
9	Myocardial myocyte remodeling and fibrosis in the cardimetabolic syndrome 显示文摘	Hayden MR Chowdhury N Govindarajan G	2006	J Cardiometab Syndr2006，1，3：	1
10	Nonalcoholic steatohepatitis and the cardiometabolic syndrome 显示文摘	AbdeenMB ChowdhuryNA HaydenMR etal	2006	J Cardiometab Syndr2006，1，：	1
11	High-dose atorvasta- tin after stroke or transient ischemic attack:The Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) Investigators 显示文摘	Karam JG Loney-Hutchinson L McFarlane SI	2008	J Cardiometab Syndr2008，3，1：	1
12	Resveratrol: biologic and therapeutic implications显示文摘	Sadruddin S Arora R	2009	J Cardiometab Syndr2009，4，2：	1
13	Statin pleiotropy against renal injury显示文摘	Sarafidis PA	2009	J Cardiometab Syndr2009，4，：	1
14	Interrelationships between inflammation, C-reactive protein, and insulin resistance显示文摘	Ndumele CE Pradhan AD Ridker PM	2006	J Cardiometab Syndr2006，1，3：	1
15	Statin pleiotropy against renal injury 显示文摘	Sarafidis PA	2009	Cardiometab Syndr2009，4，：	1
16	The diabetes subgroup baseline charac- teristics of the Avoiding Cardiovascular Events Through Combination Therapy in Patients Living With Systolic Hypertension (ACCOMPLISH) trial显示文摘	Bakris G Hester A Weber M	2008	J Cardiometab Syndr2008，3，4：	1
17	Diabetes and hypertension: epidemiology of the re-lation- ship and pathophysiology of factors associated with tbesecomorbid condi- tions 显示文摘	Schutta MH	2007	J Cardiometab Syndr2007，2，2：	1
18	C-reactive protein in cardiovascular risk assessment : a review of the evidence显示文摘	Abraham J Campbell CY Cheema A	2007	J Cardiometab Syndr2007，2，2：	1
19	The role of adiponectin in obesity, diabetes, and cardiovascular disease显示文摘	Kawano J Arora R	2009	J Cardiometab Syndr2009，4，1：	1
20	Treatment of hypertension with thiazides:benefit or damage-effect of low-and high-dose thiazide diuretics on arterial elasticity and metabolic parameters in hypertensive patients with and without glucose intolerance显示文摘	Boaz M Davidovitz I	2007	Cardiometab Syndr2007，2，1：	1

返回顶部每页显示：

共6页首页上一页第1页下一页末页 /6 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示